Kiichiro Tomoda • UCSF Profiles (original) (raw)

  1. eIF4G2-mediated selective translation of chromatin regulators safeguards adult intestinal stem cell identity and differentiation. Cell Stem Cell. 2026 Apr 30. Kunitomi H, Khaine AM, Jamee R, Arreola V, Lancero M, Raychaudhuri A, Perli S, Sato Y, Iwasaki M, Ruivo P, Tomoda K, Mito M, Shichino Y, Iwasaki S, Yamanaka S. PMID: 42066769.
    View in: PubMed Mentions:
  2. The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting. Oncol Lett. 2023 Dec; 26(6):520. Fujisaka Y, Nakagawa T, Tomoda K, Watanabe M, Matsunaga N, Tamura Y, Ikeda S, Imagawa A, Asahi M. PMID: 37927418; PMCID: PMC10623090.
    View in: PubMed Mentions:
  3. Loss of TJP1 disrupts gastrulation patterning and increases differentiation toward the germ cell lineage in human pluripotent stem cells. Dev Cell. 2023 08 21; 58(16):1477-1488.e5. Vasic I, Libby ARG, Maslan A, Bulger EA, Zalazar D, Krakora Compagno MZ, Streets A, Tomoda K, Yamanaka S, McDevitt TC. PMID: 37354899; PMCID: PMC10529434.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansCells
  4. Non-thermal atmospheric-pressure plasma potentiates mesodermal differentiation of human induced pluripotent stem cells. Heliyon. 2022 Dec; 8(12):e12009. Kobayashi M, Tomoda K, Morihara H, Asahi M, Shimizu T, Kumagai S. PMID: 36506411; PMCID: PMC9727642.
    View in: PubMed Mentions: 1
  5. Corrigendum to "ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages" [Bone. 153 2021 Dec; 116129. doi:10.1016/j.bone.2021.116129. Epub 2021 Jul 24. PMID: 34311122]. Bone. 2022 May; 158:116325. Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, Ton AN, Sharma A, Hellman J, Tomoda K, Nakamura MC, Hsiao EC. PMID: 35241401.
    View in: PubMed Mentions: Fields:
  6. ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages. Bone. 2021 12; 153:116129. Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, Ton AN, Sharma A, Hellman J, Tomoda K, Nakamura MC, Hsiao EC. PMID: 34311122; PMCID: PMC8803261.
    View in: PubMed Mentions: 20 Fields:
    Translation:HumansCells
  7. Reprogramming epiblast stem cells into pre-implantation blastocyst cell-like cells. Stem Cell Reports. 2021 05 11; 16(5):1197-1209. Tomoda K, Hu H, Sahara Y, Sanyal H, Takasato M, Kime C. PMID: 33891866; PMCID: PMC8185450.
    View in: PubMed Mentions: 4 Fields:
    Translation:AnimalsCells
  8. Synthetic embryology: Early mammalian embryo modeling systems from cell cultures. Dev Growth Differ. 2021 Feb; 63(2):116-126. Tomoda K, Kime C. PMID: 33540477.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansAnimals
  9. Fluctuation in O-GlcNAcylation inactivates STIM1 to reduce store-operated calcium ion entry via down-regulation of Ser621 phosphorylation. J Biol Chem. 2020 12 11; 295(50):17071-17082. Nomura A, Yokoe S, Tomoda K, Nakagawa T, Martin-Romero FJ, Asahi M. PMID: 33023909; PMCID: PMC7863906.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansCells
  10. Intravenously Injected Pluripotent Stem Cell-derived Cells Form Fetomaternal Vasculature and Prevent Miscarriage in Mouse. Cell Transplant. 2020 Jan-Dec; 29:963689720970456. Daimon A, Morihara H, Tomoda K, Morita N, Koishi Y, Kanki K, Ohmichi M, Asahi M. PMID: 33349053; PMCID: PMC7873769.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansAnimalsCells
  11. Overexpression of Na+/H+ exchanger 1 specifically induces cell death in human iPS cells via sustained activation of the Rho kinase ROCK. J Biol Chem. 2019 12 20; 294(51):19577-19588. Wakabayashi S, Morihara H, Yokoe S, Nakagawa T, Moriwaki K, Tomoda K, Asahi M. PMID: 31723030; PMCID: PMC6926445.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansCells
  12. Induced 2C Expression and Implantation-Competent Blastocyst-like Cysts from Primed Pluripotent Stem Cells. Stem Cell Reports. 2019 09 10; 13(3):485-498. Kime C, Kiyonari H, Ohtsuka S, Kohbayashi E, Asahi M, Yamanaka S, Takahashi M, Tomoda K. PMID: 31402336; PMCID: PMC6739768.
    View in: PubMed Mentions: 41 Fields:
    Translation:AnimalsCells
  13. BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proc Natl Acad Sci U S A. 2016 11 15; 113(46):13057-13062. Hayashi Y, Hsiao EC, Sami S, Lancero M, Schlieve CR, Nguyen T, Yano K, Nagahashi A, Ikeya M, Matsumoto Y, Nishimura K, Fukuda A, Hisatake K, Tomoda K, Asaka I, Toguchida J, Conklin BR, Yamanaka S. PMID: 27794120; PMCID: PMC5135304.
    View in: PubMed Mentions: 63 Fields:
    Translation:HumansAnimalsCells
  14. Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program. Proc Natl Acad Sci U S A. 2016 11 01; 113(44):12478-12483. Kime C, Sakaki-Yumoto M, Goodrich L, Hayashi Y, Sami S, Derynck R, Asahi M, Panning B, Yamanaka S, Tomoda K. PMID: 27738243; PMCID: PMC5098653.
    View in: PubMed Mentions: 28 Fields:
    Translation:AnimalsCells
  15. Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells. Curr Protoc Hum Genet. 2015 Oct 06; 87:21.2.1-21.2.21. Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K. PMID: 26439714.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansCells
  16. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Proc Natl Acad Sci U S A. 2015 Apr 14; 112(15):4666-71. Hayashi Y, Caboni L, Das D, Yumoto F, Clayton T, Deller MC, Nguyen P, Farr CL, Chiu HJ, Miller MD, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Tomoda K, Conklin BR, Wilson IA, Yamanaka S, Fletterick RJ. PMID: 25825768; PMCID: PMC4403148.
    View in: PubMed Mentions: 31 Fields:
    Translation:HumansAnimalsCells
  17. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. Stem Cell Reports. 2014 Aug 12; 3(2):269-81. Spencer CI, Baba S, Nakamura K, Hua EA, Sears MA, Fu CC, Zhang J, Balijepalli S, Tomoda K, Hayashi Y, Lizarraga P, Wojciak J, Scheinman MM, Aalto-Setälä K, Makielski JC, January CT, Healy KE, Kamp TJ, Yamanaka S, Conklin BR. PMID: 25254341; PMCID: PMC4175159.
    View in: PubMed Mentions: 62 Fields:
    Translation:HumansCells
  18. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell. 2012 Jul 06; 11(1):91-9. Tomoda K, Takahashi K, Leung K, Okada A, Narita M, Yamada NA, Eilertson KE, Tsang P, Baba S, White MP, Sami S, Srivastava D, Conklin BR, Panning B, Yamanaka S. PMID: 22770243; PMCID: PMC3396435.
    View in: PubMed Mentions: 58 Fields:
    Translation:HumansCells
  19. G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. PLoS One. 2009 Nov 10; 4(11):e7780. Nakamura K, Salomonis N, Tomoda K, Yamanaka S, Conklin BR. PMID: 19936228; PMCID: PMC2777408.
    View in: PubMed Mentions: 17 Fields:
    Translation:HumansAnimalsCells
  20. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30; 131(5):861-72. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. PMID: 18035408.
    View in: PubMed Mentions: 9169 Fields:
    Translation:HumansAnimalsCells
  21. Preparation and characterization of monoclonal antibodies against mouse Jab1/CSN5 protein. Hybridoma (Larchmt). 2006 Dec; 25(6):342-8. Kato JY, Nakamae I, Tomoda K, Fukumoto A, Yoneda-Kato N. PMID: 17203996.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansAnimalsCells
  22. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines. FEBS Lett. 2006 Oct 30; 580(25):5836-44. Fukumoto A, Tomoda K, Yoneda-Kato N, Nakajima Y, Kato JY. PMID: 17027978.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansAnimalsCells
  23. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 2005 May 04; 24(9):1739-49. Yoneda-Kato N, Tomoda K, Umehara M, Arata Y, Kato JY. PMID: 15861129; PMCID: PMC1142586.
    View in: PubMed Mentions: 46 Fields:
    Translation:AnimalsCells
  24. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation. FEBS Lett. 2005 Feb 14; 579(5):1047-54. Fukumoto A, Tomoda K, Kubota M, Kato JY, Yoneda-Kato N. PMID: 15710389.
    View in: PubMed Mentions: 26 Fields:
    Translation:AnimalsCells
  25. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood. 2005 Jan 15; 105(2):775-83. Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N. PMID: 15353483.
    View in: PubMed Mentions: 33 Fields:
    Translation:HumansCells
  26. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem. 2004 Oct 08; 279(41):43013-8. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. PMID: 15299027.
    View in: PubMed Mentions: 80 Fields:
    Translation:AnimalsCells
  27. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol Rep. 2004 Feb; 11(2):277-84. Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y. PMID: 14719054.
    View in: PubMed Mentions: 33 Fields:
    Translation:Humans
  28. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem. 2002 Jan 18; 277(3):2302-10. Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY. PMID: 11704659.
    View in: PubMed Mentions: 113 Fields:
    Translation:AnimalsCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs